Cetera Investment Advisers Adma Biologics, Inc. Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
A detailed history of Cetera Investment Advisers transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 66,495 shares of ADMA stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,495
Previous 50,511
31.64%
Holding current value
$1.03 Million
Previous $1 Million
20.76%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
398Shares Held
191MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$289 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$199 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$187 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$91.7 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.04B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...